NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
24/03/2026
Voltar para busca
Dado oficial do USPTO
WORLDWIDE EVIDENCE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
WORLDWIDE EVIDENCE
ST13
US500000087689214Classe
35, 41, 42
Pedido
87689214
Registro
5777758
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
25/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 41, 42
Data de depósito
17/11/2017
Data de registro
11/06/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/03/2026
Última transação
25/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
701
Cadastro oficial
Supplemental Register
Fundamento do pedido
Intent to use
Primeiro uso
30/06/2018
Primeiro uso no comércio
30/06/2018
Código do desenho
4
Tipo de titular
03
Localização do titular
Durham, NC, US
Examinador
LORENZO, KATHLEEN H
Localização atual
Historical data usage
Titulares e representantes
Titulares
Worldwide Clinical Trials, Inc.
Worldwide Clinical Trials, Inc.
Representantes
Lindsay Lehrer Worldwide Clinical Trials, Inc.
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting and management in the field of clinical trials; Pharmaceutical cost management services and drug utilization review services; Business management assistance and consultation for clinical trials of observational research designsmanagement and compilation of information in the field of clinical trials for business purposessurveysretrospective chart reviewprospective longitudinal cohort studiespost approval safety studies (pass)registriesinterventional studies for approved and investigational drugs; Business management servicesarranging for sites to perform clinical trialsarranging for the importpackagingshipping labelingdistribution of drugs and other investigational supplies to and from the clinical trial sites as appropriate to the study designarranging for the central collection of laboratory specimens from clinical trial sitesextracting data from clinical trial records including electronic healthcare recordsmaking any and all filings required by the food and drug administration as well as the EMA for observational researchas appropriate investigational new drugspreparing statistical reports resulting from clinical trials an studiesall for business purposes
Classe 41
Training clinical trial site personnel concerning protocol requirements and the use of tests and rating systems for such protocol; training clinical trial site personnel in the use of medical and research equipment and procedures required by protocols
Classe 42
Pharmaceutical research services; Pharmaceutical research and development; Technical writing of clinical report forms for others which are required by clinical trial study protocols; Technical writing of clinical trial reports for others; Database development services to process data collected from clinical trials
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
24/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/03/2026
ES8R
TEAS SECTION 8 RECEIVED
04/11/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/06/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
20/12/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/09/2022
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
11/06/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/05/2019
ALIE
ASSIGNED TO LIE
29/04/2019
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
19/04/2019
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
18/04/2019
IUAA
USE AMENDMENT ACCEPTED
18/04/2019
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
16/04/2019
IUAF
USE AMENDMENT FILED
16/04/2019
EAAU
TEAS AMENDMENT OF USE RECEIVED
15/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/04/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
15/10/2018
GNFR
FINAL REFUSAL E-MAILED
15/10/2018
CNFR
FINAL REFUSAL WRITTEN
15/10/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/09/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/03/2018
GNRT
NON-FINAL ACTION E-MAILED
12/03/2018
CNRT
NON-FINAL ACTION WRITTEN
12/03/2018
DOCK
ASSIGNED TO EXAMINER
02/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/11/2017
NWAP
NEW APPLICATION ENTERED
21/11/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace WORLDWIDE EVIDENCE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.